Evidence map›Paper›PMID 39594256›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Four-Dimensional Flow MRI for Cardiovascular Evaluation (4DCarE): A Prospective Non-Inferiority Study of a Rapid Cardiac MRI Exam: Study Protocol and Pilot Analysis.

Jiaxing Jason Qin, Mustafa Gok, Alireza Gholipour, Jordan LoPilato, Max Kirkby, Christopher Poole, Paul Smith, Rominder Grover, Stuart M Grieve

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiaxing Jason QinImaging and Phenotyping Laboratory, Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0002-8428-6311
Mustafa GokImaging and Phenotyping Laboratory, Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0001-7021-0984
Alireza GholipourImaging and Phenotyping Laboratory, Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia.
Jordan LoPilatoANU Medical School, Australian National University, Canberra, ACT 2601, Australia.ORCID 0000-0003-4042-0934
Max KirkbyImaging and Phenotyping Laboratory, Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia.
Christopher PooleImaging and Phenotyping Laboratory, Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia.
Paul SmithEpworth Radiology, Waurn Ponds, VIC 3216, Australia.
Rominder GroverMacquarie University Hospital, Macquarie Park, NSW 2109, Australia.
Stuart M GrieveImaging and Phenotyping Laboratory, Charles Perkins Centre, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0002-2712-157X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccurate measurements of flow and ventricular volume and function are critical for clinical decision-making in cardiovascular medicine. Cardiac magnetic resonance (CMR) is the current gold standard for ventricular functional evaluation but is relatively expensive and time-consuming, thus limiting the scale of clinical applications. New volumetric acquisition techniques, such as four-dimensional flow (4D-flow) and three-dimensional volumetric cine (3D-cine) MRI, could potentially reduce acquisition time without loss in accuracy; however, this has not been formally tested on a large scale.

methods4DCarE (4D-flow MRI for cardiovascular evaluation) is a prospective, multi-centre study designed to test the non-inferiority of a compressed 20 min exam based on volumetric CMR compared with a conventional CMR exam (45-60 min). The compressed exam utilises 4D-flow together with a single breath-hold 3D-cine to provide a rapid, accurate quantitative assessment of the whole heart function. Outcome measures are (i) flow and chamber volume measurements and (ii) overall functional evaluation. Secondary analyses will explore clinical applications of 4D-flow-derived parameters, including wall shear stress, flow kinetic energy quantification, and vortex analysis in large-scale cohorts. A target of 1200 participants will enter the study across three sites. The analysis will be performed at a single core laboratory site. Pilot Results: We present a pilot analysis of 196 participants comparing flow measurements obtained by 4D-flow and conventional 2D phase contrast, which demonstrated moderate-good consistency in ascending aorta and main pulmonary artery flow measurements between the two techniques. Four-dimensional flow underestimated the flow compared with 2D-PC, by approximately 3 mL/beat in both vessels.

conclusionsWe present the study protocol of a prospective non-inferiority study of a rapid cardiac MRI exam compared with conventional CMR. The pilot analysis supports the continuation of the study. STUDY REGISTRATION: This study is registered with the Australia and New Zealand Clinical Trials Registry (Registry number ACTRN12622000047796, Universal Trial Number: U1111-1270-6509, registered 17 January 2022-Retrospectively registered).

Indexed as

4D-flowcardiac imagingcardiac magnetic resonance imagingimaging analysisleft ventricular function

Identifiers

PMID39594256
PMCPMC11593203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.